| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC1732 |
| Trial ID | NCT03159585 |
| Disease | Stomach Cancer | Ovarian Cancer | Thyroid Cancer | Liver Cancer | Esophageal Cancer | Breast Cancer | Prostate Carcinoma | Bladder Carcinoma |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | TAEST16001 |
| HLA | HLA-A*02:01 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Application of NY-ESO-1-specific TCR Affinity Enhancing Specific T Cell Therapy (TAEST16001) in Solid Tumors Except Non Small Cell Lung Cancer,Including Liver Cancer,Gastric Cancer,Esophageal Cancer and so on. |
| Year | 2017 |
| Country | China |
| Company sponsor | Zhujiang Hospital |
| Other ID(s) | 2017-ZLZX-001 |
| Cohort 1 | |||||||||
|
|||||||||